The Current Ratio as of December 2025 (TTM) for Zenas BioPharma, Inc. (ZBIO) is 5.23

According to Zenas BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.23. This represents a change of -22.09% compared to the average of 6.72 of the last 4 quarters.

Zenas BioPharma, Inc. (ZBIO) Historical Current Ratio (quarterly & annually)

How has ZBIO Current Ratio performed in the past?

The mean historical Current Ratio of Zenas BioPharma, Inc. over the last ten years is 3.81. The current 5.23 Current Ratio has changed 13.65% with respect to the historical average. Over the past ten years (40 quarters), ZBIO's Current Ratio was at its highest in in the September 2024 quarter at 8.95. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Zenas BioPharma, Inc. (ZBIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Zenas BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zenas BioPharma, Inc. (ZBIO) Average Current Ratio

How has ZBIO Current Ratio performed in the past?

The current Current Ratio of Zenas BioPharma, Inc. (ZBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zenas BioPharma, Inc. (ZBIO) Current Ratio vs. Peers

How is ZBIO’s Current Ratio compared to its peers?

Zenas BioPharma, Inc.’s Current Ratio is less than Upstream Bio, Inc. (38.27), less than Intellia Therapeutics, Inc. (6.21), greater than Syndax Pharmaceuticals, Inc. (4.64), greater than Wave Life Sciences Ltd. (2.51), less than Relay Therapeutics, Inc. (19.14), greater than Novavax, Inc. (2.27), less than Amylyx Pharmaceuticals, Inc. (13.70), less than ORIC Pharmaceuticals, Inc. (14.65), less than Trevi Therapeutics, Inc. (21.93), greater than Inhibrx Biosciences, Inc. (4.49),

Build a custom stock screener for Zenas BioPharma, Inc. (ZBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zenas BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zenas BioPharma, Inc. (ZBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zenas BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.